Table 1.
Clinical data: Demographic data, characteristics of disease and interventiona.
| eGOS ≤ 5 (n = 69, 61·6%)b | eGOS > 5 (n = 43, 38·4%)b | OR (95% CI) | p-value | PC (n = 78, 62·9%) | NPC (n = 46 37·1%) | OR (95% CI) | p-value | |
|---|---|---|---|---|---|---|---|---|
| Sex | 0·6757 | 0·5524 | ||||||
| Female | 46 | 31 | .. | 51 | 33 | .. | ||
| Male | 23 | 12 | .. | 27 | 13 | .. | ||
| Neurological score at admission | ||||||||
| WFNS ≥ 4 | 46 | 14 | 4·14 (1·84–9·32) | 0·0005 | 49 | 17 | 3·31 (1·46–6·52) | 0·0018 |
| WFNS < 4 | 23 | 29 | 29 | 31 | ||||
| RMS > 4 | 63 | 23 | 9·13 (3·26–25·57) | 0·0000 | 68 | 27 | 4·79 (1·97–11·61) | 0·0004 |
| RMS≤4 | 6 | 20 | 10 | 19 | ||||
| Aneurysm locationc | 0·7695 | 0·8350 | ||||||
| ACA | 3 | 2 | .. | 3 | 2 | .. | ||
| MCA | 26 | 15 | .. | 29 | 18 | .. | ||
| ICA | 3 | 4 | .. | 4 | 4 | .. | ||
| ACoP | 11 | 6 | .. | 12 | 6 | .. | ||
| ACoA | 21 | 14 | .. | 25 | 14 | .. | ||
| PeriA | 0 | 1 | .. | 0 | 1 | .. | ||
| BCA | 3 | 0 | .. | 3 | 0 | .. | ||
| PICA | 2 | 1 | .. | 2 | 1 | .. | ||
| Type of intervention | 0·7631 | 0·5683 | ||||||
| Clipping | 60 | 39 | 0·68 (0·20–2·37) | 68 | 42 | 0·65 (0·19–2·20) | ||
| Coiling | 9 | 4 | 10 | 4 | ||||
| Presence of vasospasm | 0·2946 | 0·1347 | ||||||
| V- | 17 | 12 | .. | 19 | 16 | .. | ||
| V−/+ | 21 | 18 | .. | 23 | 17 | .. | ||
| V+ | 31 | 13 | .. | 36 | 13 | .. | ||
| Arterial hypertensiond | 0·0013 | 0·0153 | ||||||
| True | 40 | 13 | 3·69 (1·63–8·39) | 42 | 16 | 2·46 (1·15–5·27) | ||
| Not true | 25 | 30 | 32 | 30 | ||||
| Anemiad | 0·0266 | 0·0309 | ||||||
| True | 17 | 3 | 3·98 (1·06–15·00) | 18 | 3 | 3·77 (1·01–14·01) | ||
| Not true | 37 | 26 | 43 | 27 | ||||
| Abnormal liver enzymesd | 0·4688 | 0·3716 | ||||||
| True | 19 | 8 | .. | 23 | 8 | .. | ||
| Not true | 38 | 19 | .. | 41 | 19 | .. | ||
| Uric acidd | 0·5021 | 0·2708 | ||||||
| Below normal | 24 | 11 | .. | 29 | 9 | .. | ||
| Normal | 19 | 10 | .. | 20 | 10 | .. | ||
| Total cholesterold | 0·9686 | 0·9811 | ||||||
| Evaluated | 1 | 2 | .. | 1 | 2 | .. | ||
| Normal | 38 | 17 | .. | 43 | 15 | .. | ||
| Previous aSAH | 1·0000 | 1·0000 | ||||||
| True | 0 | 1 | .. | 0 | 1 | .. | ||
| Not true | 69 | 42 | .. | 78 | 45 | .. | ||
OR = odds ratio. PC = progressive course of aSAH. NPC = non-progressive course of aSAH.
a
Only significant OR values were presented in the table.
b
Neurological outcome (eGOS) was available for 112 (90%) patients.
c
Aneurysms were assessed using four-vessel digital subtraction angiography (DSA).
d
Clinical data were not available for all of the patients.